PMID: 702058Oct 1, 1978Paper

Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes

The Journal of Experimental Medicine
G LavieE C Franklin

Abstract

Peripheral blood monocytes incubated in a serum-free medium degraded serum amyloid A (SAA) protein along three pathways. Of 20 normal subjects, 8 degraded SAA completely with no detectable intermediates. Eight subjects transiently produced an amyloid A (AA)-like intermediate which comigrated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (PAGE) with tissue AA protein and reacted with antisera to AA, whereas four subjects yielded a persistent AA-like intermediate on PAGE. This group also failed to degrade tissue AA protein. Cells from 10 patients with amyloidosis fell into the second group. The responsible enzymes appear to be serine proteases because they are inhibited by disopropyl fluorophosphate. They were not affected by epsilon-amino caproic acid, L-1-tosylamide-2-phenylethyl chloromethyl ketone, or N-alpha-p-tosyl-L-lysine chlormethyl ketone. It appears possible that the enzymes are associated with the outer membrane of the cell because only a small fraction of the activity is secreted into the medium and because enzyme activity remains after fixation of the cells with glutaraldehyde which completely stops phagocytosis. Perhaps differences in patterns of proteolysis may play a role in the predisposition to a...Continue Reading

References

Apr 1, 1975·The Journal of Clinical Investigation·C J Rosenthal, E C Franklin
Aug 1, 1975·The Journal of Experimental Medicine·Z Werb, S Gordon
Aug 1, 1975·The Journal of Experimental Medicine·Z Werb, S Gordon
Aug 1, 1977·The Journal of Experimental Medicine·P WestermarkB Johansson
Mar 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·N EriksenE P Benditt
Apr 1, 1974·The Journal of Clinical Investigation·G Husby, J B Natvig
Sep 1, 1974·The Journal of Experimental Medicine·M SkinnerM D Benson
Aug 1, 1972·Biochemistry·M A HermodsonE P Benditt
Jan 1, 1972·Scandinavian Journal of Immunology·G HusbyJ B Natvig
Apr 1, 1974·The Journal of Experimental Medicine·J C UnkelessE Reich
Oct 1, 1972·The Journal of Clinical Investigation·M LevinM Pras
Apr 27, 1971·Biochimica Et Biophysica Acta·M Skinner, A S Cohen
Apr 1, 1968·The Journal of Clinical Investigation·M PrasE C Franklin
Nov 21, 1964·Nature·A BOYUM

❮ Previous
Next ❯

Citations

Jan 1, 1990·Journal of Clinical Laboratory Analysis·A OunanianS Avrameas
Jan 1, 1989·Archives of Dermatological Research·K Ito, K Hashimoto
Jan 1, 1984·Rheumatology International·C P Maury
Jun 30, 1983·Clinica Chimica Acta; International Journal of Clinical Chemistry·C P MauryM P Salaspuro
Sep 1, 1993·Atherosclerosis·E MalleJ G Raynes
Jan 1, 1986·Molecular Immunology·F E DwuletM D Benson
Mar 19, 1987·Biochimica Et Biophysica Acta·J MelroseT K Taylor
Jan 1, 1986·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·P WestermarkD W Hayden
Jan 1, 1989·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·K H JohnsonP Westermark
Sep 13, 1980·Lancet·D Harman
Jun 28, 1980·Lancet·A F Strachan, P M Johnson
Jun 28, 1980·Lancet·E A Clarke, T W Anderson
Mar 29, 1979·Nature·J R Wohlgethan, E S Cathcart
Apr 12, 2001·Clinical and Experimental Immunology·K MigitaK Eguchi
May 12, 1983·The New England Journal of Medicine·D Zucker-Franklin, B Frangione
Dec 1, 1980·The Journal of Experimental Medicine·E Remold-O'Donnell
May 1, 1985·The Journal of Experimental Medicine·A Fuks, D Zucker-Franklin
Dec 1, 1994·Scandinavian Journal of Immunology·S YakarM Pras
Jul 1, 1980·Acta Pathologica Japonica·T SuzukiS Oboshi
Dec 1, 1992·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·M CoutinhoA E Davis
May 4, 1999·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·J JákóI Vályi-Nagy
Jan 1, 1989·Journal of Veterinary Internal Medicine·S P DiBartola, M D Benson
Dec 1, 1980·Journal of Clinical Pathology·G G Cornwell, P Westermark
Apr 25, 2000·Annual Review of Medicine·J N Buxbaum, C E Tagoe
Sep 1, 1981·The Journal of Clinical Investigation·H E Jasin, J T Dingle
Jan 27, 2009·BMC Immunology·Berardo de Jesus RodriguezHenri Salmon
Aug 1, 1983·Hoppe-Seyler's Zeitschrift für physiologische Chemie·K SlettenG Husby
Jun 16, 1999·Clinical Chemistry and Laboratory Medicine : CCLM·T Yamada
Jan 1, 1980·La Ricerca in Clinica E in Laboratorio·E C FranklinD Zucker-Franklin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
E P Benditt, N Eriksen
Scandinavian Journal of Immunology
B Skogen, J B Natvig
© 2021 Meta ULC. All rights reserved